470
Views
314
CrossRef citations to date
0
Altmetric
Research Article

The Usefulness of a Structured Questionnaire in the Assessment of Symptomatic Gastroesophageal Reflux Disease

Pages 1023-1029 | Published online: 08 Jul 2009

References

  • Spechler S. Epidemiology and natural history of gastrooesophageal reflux disease. Digestion 1992;51 Suppl 1:24–9.
  • Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989;24 Suppl 156:7–13.
  • Heading RC. Epidemiology of oesophageal reflux disease. Scand J Gastroenterol 1989;24 Suppl 168:33–7.
  • Johnsson F, Joelsson B, Gudmundsson K, Greiff L. Symptoms and endoscopic findings in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroenterol 1987;22:714–8.
  • Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet 1990;335:205–8.
  • Venables TL, Newland RD, Patel AC, Hole J, Wilcock C, Turbitt ML. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997;32:965–73.
  • Jones RH, Hungin PAS, Phillips J, Mills JG. Gastro-oesophageal reflux diasease in primary care in Europe: clinical presentation and endoscopic findings. Eur J Gen Pract 1995;1:149–54.
  • Murphy DW, Yuan Y, Castell DO. Does the intraesophageal pH probe accurately detect acid reflux? Simulataneous recording with two pH probes in humans. Dig Dis Sci 1989;34:649–56.
  • Masclee AAM, de Best ACAM, de Graaf R, Cluysenaer OJJ, Jansen JBMJ. Ambulatory 24-hour pH-metry in the diagnosis of gastroesophageal reflux disease. Determination of criteria and relation to endoscopy. Scand J Gastroenterol 1990;25: 225–30.
  • Ghillibert G, Demeyere AM, Janssens J, Vantrappen G. How well can quantitative 24-hour intraesophageal pH monitoring distinguish various degrees of reflux disease? Dig Dis Sci 1995;40:1317–24.
  • Shi G, Bruley des Varannes S, Scarpignato C, Le Ruhn M, Galmiche J-P. Reflux related symptoms in patients with normal oesophageal acid exposure to acid. Gut 1995;37:457–64.
  • Joelsson B, Johnsson F. Heartburn—the acid test. Gut 1989; 30:1523–5.
  • Jones RH, Lydeard SE, Hobbs FDR, Kenkre JE, Williams EI, Jones SJ, et al. Dyspepsia in England and Scotland. Gut 1990;31:401–5.
  • Castell DO, Holtz A. Gastroesophageal reflux. Don’t forget to ask about heartburn. Postgrad Med 1989;86:141–8.
  • Savary M, Miller G. L’oesophage. In: Savary M, Miller G, editors. Manuel et atlas d’endoscopie. Soleure: Gassmann AG; 1977. p. 135.
  • Sandmark S, Carlsson R, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results from a double-blind, randomized, multicentre study. Scand J Gastroenterol 1988;23:625–32.
  • Carlsson R, Dent J, Watts R, Riley S, Sheikh R, Hatlebakk J, et al. Gastro-oesophageal reflux disease in primary care—an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1998;10:119–24.
  • Lauritsen K, Aalycke C, Havelund T, Knudsen T, Glise H, Unge P, et al. Effect of omeprazole in functional dyspepsia: arandomized, placebo-controlled study. Gastroenterology 1996; 110:A702.
  • Armstrong D, Bennett JR, Blum AL, Dent J, de Dombal FT, Galmiche J-P, et al. Endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111:85–92.
  • Talley NJ, Colin-Jones D, Koch KL, Koch M, Nyrén O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenterol Int 1991;4:145–60.
  • Locke RG, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994;69:539–47.
  • Johnsson F, Roth Y, Damgaard Pedersen N-E, Joelsson B. Cimetidine improves GERD symptoms in patients selected by a validated GERD questionnaire. Aliment Pharmacol Ther 1993;7:81–6.
  • Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495–8.
  • Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm value as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastrenterol 1996;31 Suppl 221:8–13.
  • Colin-Jones DG, Bloom B, Bodemar G, Crean G, Freston J, Gugler R, et al. Management of dyspepsia: Report of a working party. Lancet 1988;1:576–9.
  • Talley NJ, Zinsmeister AR, Schleck CD, Melton JL. Dyspepsia and dyspepsia subgroups: A population-based study. Gastroenterology 1992;102:1259–68.
  • Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996;91:660–73.
  • Klauser AG, Voderholzer WA, Knesewitsch PA, Schindlbeck NE, Muller-Lissner SA. What is behind dyspepsia? Dig Dis Sci 1993;38:147–54.
  • Johannesen T, Fjosne U, Kleveland PM, Halvorsen T, Kristensen P, Loge I, et al. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988;23:327–36.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.